Navigation Links
Gene Study Offers Hope of Potent Anti-cancer Drugs

A study has opened the way for a new generation of drugs to combat the genes that give rise to the growth// of cancer tumors.

Scientists have carried out the widest survey yet of the genetic errors that causes tumors to grow. The findings will be used to design anti-cancer drugs targeted at counteracting mutations in a patient's DNA.

All cancers are thought to result from an accumulation of mutations in one or another of the 30,000 genes in the human genome. These mutations cause a cell to multiply uncontrollably to form a tumor that can then spread to other parts of the body.

Scientists have identified about 350 genes that have been implicated in the development of different cancers but, until now, have not had a clear idea about how many mutations in these genes were directly involved in triggering cancer.

The latest study analyzed 200 samples of cancerous tissue, surveying 500 genes and sequencing more than 250 million letters of the DNA code. An international team of more than 60 scientists led by Michael Stratton of the Wellcome Trust Sanger Institute in Cambridge identified 158 mutations in 120 genes that they believe can be implicated in cancer development.

Professor Stratton said the number of mutations that appear to be involved in driving the growth of cancerous tumors was larger than expected, but ultimately the technique will allow scientists to acquire a complete catalogue of all the mutations involved in each class of cancer.

"The human genome is a vast place and this, our first systematic exploration in cancer, has thrown up many surprises," said Professor Stratton. "We have found a much larger number of mutated driver genes produced by a wider range of forces than we expected. It's important because the more cancer genes we find, the more targets we'll have in terms of potential new drugs."

The study, published in the journal Nature, compared the genetic sequence of the DNA derived from a patient's tumor cells with the DNA of healthy cells from the same patient. The aim was to find the mutations that are present only in the tumor cells, and which could be implicated in their growth.

The scientists concentrated on a class of gene called the kinases, which are known to play a role in cancer. They identified about 1,000 mutations in these genes. The next stage was to try to assess whether these mutations were directly involved in "driving" cancer development, or whether they were harmless "passenger" mutations, which accumulate in the body with age.

Andrew Futreal, a senior team member at the Sanger, said some 158 driver mutations were identified in 120 of the kinase genes studied by the scientists.

"It turns out that most mutations in cancers are passengers. However, buried amongst them are much larger numbers of driver mutations than was previously anticipated," said Dr Futreal. "This suggests that many more genes contribute to cancer development than was thought.

"This study vindicates all of the effort that went into the Human Genome Project. Understanding the mutations that cause cancer is crucial in order to develop accurately targeted treatments," said Mark Walport, director of the Wellcome Trust.

Source-Bio-Bio Technology
'"/>




Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2017)... ... August 17, 2017 , ... Centrifugation is more than just spinning. Like ... we can no longer do without. And just like a car, there are a ... In this webinar, attendees will learn about the most important safety aspects while using ...
(Date:8/16/2017)... ... August 16, 2017 , ... Summer days spent with family are priceless. Since ... together suggestions for enjoying the season of sunshine. Add trying something new to this ... can join in on the fun. , Try Something New , ...
(Date:8/16/2017)... ... August 16, 2017 , ... Greenfield Advisors is honored to be named to ... second year in a row. The Inc. 5000 list honors private businesses across the ... on the list once is a great accomplishment, but for us to be included ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... with a New England student to educate the public on the impact of ... for launching the first-ever National Concussion Awareness Day. , Brooke is working diligently ...
(Date:8/16/2017)... ... August 16, 2017 , ... Modern Consulting Insurance ... enrichment program. Partnering once again with Boys & Girls Clubs of Greater Kansas ... the area’s very own American Idol. With all proceeds benefitting local worthy causes, ...
Breaking Medicine News(10 mins):
(Date:7/31/2017)...  Diplomat Pharmacy, Inc. (NYSE: DPLO), has been named one ... by Crain,s Detroit Business . The annual ... three-year revenue growth. This year,s edition measures growth from 2013 ... the complete list, visit crainsdetroit.com/awards/fast_50/2017 .  ... said Phil Hagerman , CEO and chairman of Diplomat. ...
(Date:7/28/2017)... , July 28, 2017 EnvoyHealth, a Diplomat ... pilot a program for CleverCap LITE, a technology designed ... strives to deliver innovative health technology solutions and services ... CleverCap LITE offers medication ... high-tech bottle cover: ...
(Date:7/26/2017)... -- Radium Medical Aesthetics, a leading medical aesthetic clinic in ... addressing several skin conditions from the inside. The natural ... fragile. The skin becomes more transparent due to the thinning of ... rays from the sun contributes to aging skin, causing age spots ... ...
Breaking Medicine Technology: